RECOMBINANT MODIFIED ANKARA VIRAL HIV-1 VACCINES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

12055619

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The field of the present invention relates to novel recombinant MVA vectors encoding one or more HIV-1 immunogens as an HIV-1 vaccine candidate and methods of using same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INTERNATIONAL AIDS VACCINE INITIATIVE125 BROAD STREET 9TH FLOOR NEW YORK NY 10004

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Excler, Jean-Louis Trelex, CH 1 1
Fast, Patricia E New York, NY 7 79

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation